| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Pharmaceuticals & Drugs
|
Compare with Industry peers |
| Website | http://www.wockhardt.com | |
| Market Cap | 8,966.28 Cr. | |
| Enterprise Value(EV) | 10,892.95 Cr. | 2023-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | -32.72 | Trailing Twelve Months Ending 2023-12 |
| Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2023-12 |
| Industry PE | 40.78 | Trailing Twelve Months Ending 2023-12 |
| Book Value / Share | 229.41 | Trailing Twelve Months Ending 2023-12 |
| Price to Book Value | 2.55 | Calculated using Price: 584.50 |
| Dividend Yield | 0.00 | Period Ending 2023-03 |
| No. of Shares Subscribed | 15.34 Cr. | 153,400,936 Shares |
| FaceValue | 5 | |
| About Wockhardt Ltd. | ||
| The company is a pharmaceutical and biotechnology company. The Company's businesses include manufacture and marketing of pharmaceutical and bio-pharmaceutical formulations, active pharmaceutical ingredients (APIs) and vaccines. It has many research centres and several manufacturing plants, with businesses ranging from the manufacture and marketing of Pharmaceutical and Bio-pharmaceutical formulations, Active Pharmaceutical Ingredients (APIs) and Vaccines. It is a business in transition. New and innovative business models are in motion to make the most of emerging opportunities. A new drive for growth today permeates every mind-set, process and techno-innovation within Wockhardt. | ||
| 1 Day |
|
+1.99% |
| 1 Week |
|
+1.50% |
| 1 Month |
|
+9.29% |
| 3 Month |
|
+28.15% |
| 6 Month |
|
+140.89% |
| 1 Year |
|
+235.92% |
| 2 Year |
|
+102.70% |
| 5 Year |
|
+44.52% |
| 10 Year |
|
+1.41% |
| 9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
| Return on Equity (%) | 12.49 | 7.07 | -6.42 | -21.81 | -11.43 | -5.22 | -9.92 | -7.77 | -17.32 | |
| Return on Capital Employed (%) | 11.25 | 6.87 | -0.31 | -5.47 | -2.87 | -1.11 | -5.5 | -1.96 | -5.88 | |
| Return on Assets (%) | 5.84 | 3.25 | -2.69 | -7.93 | -4.01 | -1.8 | -3.93 | -3.71 | -8.42 |
| Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
| Shh. Funds | 3,715 | 3,775 | 3,337 | 2,852 | 2,675 | 2,672 | 3,376 | 3,849 | 3,354 | 3,125 | |
| Non Curr. Liab. | 1,872 | 1,893 | 3,151 | 2,089 | 1,703 | 1,195 | 496 | 261 | -22 | 739 | |
| Curr. Liab. | 1,773 | 1,842 | 1,979 | 2,692 | 2,864 | 3,497 | 3,121 | 3,207 | 3,435 | 2,685 | |
| Minority Int. | 144 | 465 | 382 | 346 | 330 | 386 | 383 | 353 | 308 | 307 | |
| Equity & Liab. | 7,505 | 7,976 | 8,849 | 7,978 | 7,571 | 7,749 | 7,376 | 7,670 | 7,075 | 6,856 | |
| Non Curr. Assets | 3,983 | 4,024 | 4,314 | 4,599 | 4,756 | 5,320 | 4,951 | 5,081 | 4,867 | 4,819 | |
| Curr. Assets | 3,522 | 3,952 | 4,535 | 3,380 | 2,815 | 2,401 | 2,281 | 2,445 | 1,914 | 2,037 | |
| Misc. Exp. not W/O | |||||||||||
| Total Assets | 7,505 | 7,976 | 8,849 | 7,978 | 7,571 | 7,749 | 7,376 | 7,670 | 7,075 | 6,856 |
| Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
| Net Sales | 4,482 | 4,453 | 4,015 | 3,937 | 3,566 | 2,844 | 2,708 | 3,230 | 2,651 | 2,776 | |
| Other Income | 67 | 66 | 114 | 177 | 21 | 60 | 132 | 20 | 122 | 78 | |
| Total Income | 4,548 | 4,519 | 4,129 | 4,114 | 3,587 | 2,904 | 2,840 | 3,250 | 2,773 | 2,854 | |
| Total Expenditure | -3,772 | -3,959 | -4,002 | -3,992 | -3,604 | -2,746 | -2,771 | -2,932 | -2,550 | -2,648 | |
| PBIDT | 776 | 560 | 127 | 122 | -17 | 158 | 69 | 318 | 223 | 206 | |
| Interest | -55 | -129 | -225 | -255 | -265 | -276 | -249 | -299 | -302 | -308 | |
| Depreciation | -145 | -142 | -149 | -150 | -164 | -224 | -246 | -247 | -251 | -221 | |
| Taxation | -163 | -38 | 21 | -26 | 135 | 204 | 271 | 132 | 3 | -99 | |
| Exceptional Items | -358 | -142 | -183 | -294 | -110 | ||||||
| PAT | 413 | 252 | -226 | -667 | -312 | -138 | -297 | -279 | -621 | -532 | |
| Minority Interest | -8 | -2 | 30 | 59 | 22 | -26 | -2 | 35 | 62 | 30 | |
| Share Associate | 1 | ||||||||||
| Other Related Items | |||||||||||
| Consolidated Net Profit | 405 | 251 | -196 | -608 | -195 | -69 | 686 | -244 | -559 | -502 | |
| Adjusted EPS | 34 | 21 | -16 | -51 | -16 | -6 | 57 | -17 | -39 | -35 |
| Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
| Cash Fr. Operatn. | 1,476 | 355 | 72 | -269 | 68 | 183 | 649 | -287 | 413 | 153 | |
| Cash Fr. Inv. | -852 | -207 | -818 | -687 | 630 | 95 | -156 | 1,470 | -201 | -125 | |
| Cash Fr. Finan. | -601 | -76 | 254 | 1,254 | -769 | -776 | -680 | -1,171 | -71 | -315 | |
| Net Change | 23 | 73 | -492 | 298 | -71 | -499 | -186 | 12 | 141 | -287 | |
| Cash & Cash Eqvt | 1,102 | 1,159 | 665 | 964 | 897 | 397 | 219 | 232 | 370 | 90 |
|
Tue, 16 Apr 2024
Certificate Pursuant To Regulation 40(10) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 ('Listing Regulations') In compliance with Regulation 40(10) of Listing Regulations please find enclosed herewith the certificate dated 15th April 2024 issued by the PCS for the year ended 31st March 2024 certifying that certificates have been issued within statutory timelines. |
|
Wed, 10 Apr 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Pursuant to Regulation 74(5) of SEBI (DP) Regulations 2018 please find enclosed compliance certificate received from Link Intime India Private Limited RTA of the Company for the quarter ended 31st March 2024. |
|
Wed, 10 Apr 2024
Compliance Certificate Under Regulation 7(3) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 ('Listing Regulations') For The Year Ended 31St March 2024. As per the requirement of Regulation 7(3) of Listing Regulations as amended we hereby confirm that all the activities in relation to share transfer facility during the period from 1st April 2023 to 31st March 2024 (both days inclusive) are maintained by Companys RTA viz Link Intime India Private Limited which is registered as RTA in Category-I with SEBI vide registration no.: INR000004058. |
| Fri, 19 Apr 2024 |
Higher Delivery Quantity
|
Higher Trade Quantity
|
Higher Trade and Delivery Quantity
|
Closing Above Previous High
|
Making Higher Highs for 3 days
|
